In vitro and in vivo CAFs-secreted exosomal SNHG3 knockdown strategies demonstrated a reversal of the metabolic reprogramming, leading to a decreased breast cancer cell glycolysis and growth [25]. This evidence concerns the gene SNHG3 and breast cancer.